You are invited to take part in a study to investigate a new vaccine for Crimean-Congo haemorrhagic fever virus. The study is being led by the Oxford Vaccine Group, which is part of the University of Oxford, and is taking place at the Centre for Clinical Vaccinology and Tropical Medicine at the Churchill Hospital.

ImmunoglobuliN in the Treatment of Encephalitis

The IgNiTE Study

A study testing a new treatment for children with encephalitis.

The Department of Paediatrics at the University of Oxford, in collaboration with NHS Trusts across the United Kingdom, is currently running a study for hospitalised children with encephalitis. The study will assess whether a treatment called intravenous immunoglobulin (IVIg, sometimes referred to as antibody treatment) has any benefit for these children when given early during the hospital admission.